Despite tremendous advances in our knowledge of the role of oxidative species in vascular disease, much debate remains regarding the mechanism by which NADPH oxidases (Nox) impart specific effects in cells.Over the past 2 decades, the term oxidative stress has often been used to describe the effects of Nox-derived reactive oxygen species (ROS).Much credence was initially given to relatively large quantities of ROS as mediators of myriad and varied cellular responses, ranging from connective tissue expression to differentiation, hypertrophy, proliferation, and apoptosis.1 With the discovery of multiple Nox isoforms and emergence of loss-of-function and gain-of-function technologies manipulating the levels of individual isoforms, a large body of literature emerged suggesting that small, localized ROS derived from individual Nox proteins can impart unique cellular responses.The lack of sophisticated detection methods for localizing perhaps subtle changes in ROS continues to stymie our understanding of how one Nox may confer activation of a specific signaling cascade and render distinct cell changes.The conundrum of why similar whole cell or tissue increases or decreases in ROS confer disparate pheno-types continues to confound leaders in the field.
No takes yet. Share an insight, caveat, or question.
Ghouleh et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: